全文获取类型
收费全文 | 871篇 |
免费 | 82篇 |
专业分类
953篇 |
出版年
2018年 | 9篇 |
2017年 | 7篇 |
2016年 | 15篇 |
2015年 | 22篇 |
2014年 | 25篇 |
2013年 | 42篇 |
2012年 | 31篇 |
2011年 | 31篇 |
2010年 | 37篇 |
2009年 | 32篇 |
2008年 | 40篇 |
2007年 | 32篇 |
2006年 | 31篇 |
2005年 | 30篇 |
2004年 | 33篇 |
2003年 | 25篇 |
2002年 | 24篇 |
2001年 | 23篇 |
2000年 | 13篇 |
1999年 | 17篇 |
1998年 | 16篇 |
1997年 | 16篇 |
1996年 | 10篇 |
1995年 | 13篇 |
1993年 | 14篇 |
1991年 | 13篇 |
1990年 | 7篇 |
1989年 | 11篇 |
1988年 | 18篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1985年 | 14篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 26篇 |
1981年 | 7篇 |
1980年 | 8篇 |
1979年 | 10篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1976年 | 11篇 |
1975年 | 11篇 |
1974年 | 7篇 |
1973年 | 9篇 |
1972年 | 8篇 |
1969年 | 8篇 |
1968年 | 7篇 |
1965年 | 7篇 |
1964年 | 8篇 |
1959年 | 8篇 |
排序方式: 共有953条查询结果,搜索用时 15 毫秒
111.
Marshall GR 《Biopolymers》2008,90(3):190-199
This personal reflection on the author's experience as Bruce Merrifield's first graduate student has been adapted from a talk given at the Merrifield Memorial Symposium at the Rockefeller University on November 13, 2006. 相似文献
112.
Back to the future: ribonuclease A 总被引:1,自引:0,他引:1
Pancreatic ribonuclease A (EC 3.1.27.5, RNase) is, perhaps, the best-studied enzyme of the 20th century. It was isolated by René Dubos, crystallized by Moses Kunitz, sequenced by Stanford Moore and William Stein, and synthesized in the laboratory of Bruce Merrifield, all at the Rockefeller Institute/University. It has proven to be an excellent model system for many different types of experiments, both as an enzyme and as a well-characterized protein for biophysical studies. Of major significance was the demonstration by Chris Anfinsen at NIH that the primary sequence of RNase encoded the three-dimensional structure of the enzyme. Many other prominent protein chemists/enzymologists have utilized RNase as a dominant theme in their research. In this review, the history of RNase and its offspring, RNase S (S-protein/S-peptide), will be considered, especially the work in the Merrifield group, as a preface to preliminary data and proposed experiments addressing topics of current interest. These include entropy-enthalpy compensation, entropy of ligand binding, the impact of protein modification on thermal stability, and the role of protein dynamics in enzyme action. In continuing to use RNase as a prototypical enzyme, we stand on the shoulders of the giants of protein chemistry to survey the future. 相似文献
113.
Judith van Holten Kris Reedquist Pascale Sattonet-Roche Tom JM Smeets Christine Plater-Zyberk Margriet J Vervoordeldonk Paul P Tak 《Arthritis research & therapy》2004,6(3):R239
We investigated the therapeutic potential and mechanism of action of IFN-β protein for the treatment of rheumatoid arthritis
(RA). Collagen-induced arthritis was induced in DBA/1 mice. At the first clinical sign of disease, mice were given daily injections
of recombinant mouse IFN-β or saline for 7 days. Disease progression was monitored by visual clinical scoring and measurement
of paw swelling. Inflammation and joint destruction were assessed histologically 8 days after the onset of arthritis. Proteoglycan
depletion was determined by safranin O staining. Expression of cytokines, receptor activator of NF-κB ligand, and c-Fos was
evaluated immunohistochemically. The IL-1-induced expression of IL-6, IL-8, and granulocyte/macrophage-colony-stimulating
factor (GM-CSF) was studied by ELISA in supernatant of RA and osteoarthritis fibroblast-like synoviocytes incubated with IFN-β.
We also examined the effect of IFN-β on NF-κB activity. IFN-β, at 0.25 μg/injection and higher, significantly reduced disease
severity in two experiments, each using 8–10 mice per treatment group. IFN-β-treated animals displayed significantly less
cartilage and bone destruction than controls, paralleled by a decreased number of positive cells of two gene products required
for osteoclastogenesis, receptor activator of NF-κB ligand and c-Fos. Tumor necrosis factor α and IL-6 expression were significantly
reduced, while IL-10 production was increased after IFN-β treatment. IFN-β reduced expression of IL-6, IL-8, and GM-CSF in
RA and osteoarthritis fibroblast-like synoviocytes, correlating with reduced NF-κB activity. The data support the view that
IFN-β is a potential therapy for RA that might help to diminish both joint inflammation and destruction by cytokine modulation. 相似文献
114.
The anti-PM/Scl autoantibodies are known to characterize a subset of autoimmune patients with myositis, scleroderma (Scl), and the PM/Scl overlap syndrome. The major autoantigens that are recognized by anti-PM/Scl autoantibodies are designated PM/Scl-100 and PM/Scl-75. These autoantigens have been reported to associate into a large complex consisting of 11 to 16 proteins and to play a role in ribosome synthesis. Recently, it was discovered that the PM/Scl complex is the human counterpart of the yeast (Saccharomyces cerevisiae) exosome, which is an RNA-processing complex consisting of 11 3' → 5' exoribonucleases. To date, 10 human exosome components have been identified, although only some of these were studied in more detail. In this review, we discuss some recent advances in the characterization of the PM/Scl complex. 相似文献
115.
Editors' Introduction 总被引:2,自引:0,他引:2
116.
Endothelium-dependent hyperpolarizing factor (EDHF) underlies nitric oxide and prostacyclin-independent arterial relaxation. As the influence of EDHF increases with decreasing artery size, it plays an important role in vascular regulation. Initially suggested to represent a diffusible factor, EDHF is now thought to represent a variable input in different arteries from a factor(s) and the spread of hyperpolarizing current from the endothelium to the smooth muscle. Key to unravelling this pathway has been the demonstration that hyperpolarization within the endothelium can be blocked using a combination of the KCa channel blockers, apamin and charibdotoxin. As a consequence, the relaxation of vascular smooth muscle, which represents the end point of the EDHF pathway, is blocked. This review discusses the evidence that a differential distribution of ion channels between the smooth muscle and endothelial cells underlies the EDHF pathway. Also, that a diffusible factor, which may well be K ions released by the endothelium, acts alongside the spread of hyperpolarization through myoendothelial gap junctions to explain EDHF-evoked smooth muscle relaxation. While the relative importance of each of these two components can vary between arteries, together they can explain the EDHF phenomenon. 相似文献
117.
118.
Marsupials are often considered inferior to placental mammals in a number of physiological characters. Because locomotor performance is presumed to be an important component of fitness, we compared marsupials and placentals with regard to both maximal running speeds and maximal aerobic speeds (=speed at which the maximal rate of oxygen consumption, VOlmax, is attained). Maximal aerobic speed is related to an animal's maximal sustainable speed, and hence is a useful comparative index of stamina.
Maximal running speeds of 11 species of Australian marsupials, eight species of Australian murid rodents, two species of American didelphid marsupials, and two species of American rodents were measured in the laboratory and compared with data compiled from the literature. Our values are greater than, or equivalent to, those reported previously. Marsupials and placentals do not differ in maximal running speeds (nor do Australian rodents differ from non-Australian rodents). Within these groups, however, species and families may differ considerably. Some of the interspecific variation in maximal running speeds is related to differences in habitat: species inhabiting open habitats (e.g. deserts) tend to be faster than are species from habitats with more cover, or arboreal species.
Maximal aerobic speeds (compiled from the literature) were higher in large species than in small species. However, marsupials and placentals show no general difference with regard to maximal aerobic speeds.
Maximal running speeds and maximal aerobic speeds for 18 species of mammals were not correlated, after correcting for correlations with body size. Thus, the fastest sprinters do not necessarily have high maximal aerobic speeds. 相似文献
Maximal running speeds of 11 species of Australian marsupials, eight species of Australian murid rodents, two species of American didelphid marsupials, and two species of American rodents were measured in the laboratory and compared with data compiled from the literature. Our values are greater than, or equivalent to, those reported previously. Marsupials and placentals do not differ in maximal running speeds (nor do Australian rodents differ from non-Australian rodents). Within these groups, however, species and families may differ considerably. Some of the interspecific variation in maximal running speeds is related to differences in habitat: species inhabiting open habitats (e.g. deserts) tend to be faster than are species from habitats with more cover, or arboreal species.
Maximal aerobic speeds (compiled from the literature) were higher in large species than in small species. However, marsupials and placentals show no general difference with regard to maximal aerobic speeds.
Maximal running speeds and maximal aerobic speeds for 18 species of mammals were not correlated, after correcting for correlations with body size. Thus, the fastest sprinters do not necessarily have high maximal aerobic speeds. 相似文献
119.
120.
Fluorescence photobleaching recovery: control of laser intensities with an acousto-optic modulator. 总被引:4,自引:0,他引:4 下载免费PDF全文
P Garland 《Biophysical journal》1981,33(3):481-482